In the Spotlight

January 26, 2026
Two’s Company. Three’s a Crowd. Five Nanobody® Subunits? That Could Be a New Medicine.

September 19, 2025
How We’re Redesigning Rare Disease Research
AI Across R&D

February 24, 2026
AI Across the R&D Value Chain: Portfolio Decision-Making

January 13, 2026
AI Across the R&D Value Chain: Manufacturing - Digital Labs and Self-Sharpening Tools

October 7, 2025
How Sanofi is Rewriting the Script for Untreated Rare Diseases
Everything About Our Science
Year
April 3, 2026
The Fast (And Intense) Lane: How Expedited Approvals Are Going Further and Faster for Patients
March 30, 2026
Making it Real: Turning New Scientific Breakthroughs into Reality for Patients
January 26, 2026
Two’s Company. Three’s a Crowd. Five Nanobody® Subunits? That Could Be a New Medicine.
January 6, 2026
Our Human-Centric Approach to Partnership Amidst an Evolving Biotech Landscape
November 7, 2025
Helping Patients Breathe Better: Addressing Unmet Needs in Respiratory Care
September 19, 2025
How We’re Redesigning Rare Disease Research
August 26, 2025
NANOBODY® Technology Platform
July 24, 2025
Genomic Medicine Unit: Overcoming Gene Therapy’s Greatest Challenges
June 10, 2025
